ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000231201.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.032488265	Sensitive
ENSG00000231201.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.006001992	Sensitive